Literature DB >> 7969669

Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth?

G F Nelis1, A H Engelage, G Samson.   

Abstract

OBJECTIVE: Gastric acid secretion and small intestinal motility are the main mechanisms of defense against bacterial overgrowth of the proximal digestive tract. Bacterial colonization of the stomach during gastric acid inhibition has been documented, but is probably without clinical consequence. However, small intestinal bacterial overgrowth can have serious clinical implications with malabsorption and diarrhoea.
METHODS: We prospectively investigated small intestinal bacterial overgrowth in 40 patients receiving long-term omeprazole treatment using the [14C]glycocholic breath test. Tests were performed before omeprazole treatment, after 6 weeks treatment with 40 mg o.m. and after 26 weeks treatment with 20 mg; in the test each patient served as his own control.
RESULTS: Breath tests, using individual curves, peak values, time at which the peak appeared and the area under the curve, did not differ significantly during treatment from those before treatment.
CONCLUSIONS: We conclude that long-term strong inhibition of gastric acid secretion does not lead to small intestinal bacterial overgrowth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969669

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  4 in total

1.  Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.

Authors:  K H Gan; W P Geus; C B Lamers; H G Heijerman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

2.  Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.

Authors:  C P Lakshmi; Uday C Ghoshal; Sunil Kumar; Amit Goel; Asha Misra; Samir Mohindra; G Choudhuri
Journal:  Dig Dis Sci       Date:  2009-05-08       Impact factor: 3.199

3.  Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth.

Authors:  Mark Pimentel; Edy E Soffer; Evelyn J Chow; Yuthana Kong; Henry C Lin
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 4.  Pharmacological treatment of children with gastro-oesophageal reflux.

Authors:  Mark Tighe; Nadeem A Afzal; Amanda Bevan; Andrew Hayen; Alasdair Munro; R Mark Beattie
Journal:  Cochrane Database Syst Rev       Date:  2014-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.